Inve India ▾

Zota Health Care share price & results

Zota Health Care LImited· Healthcare

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Operates Davaindia generic-pharmacy retail chain plus domestic pharma marketing and export drug manufacturing.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue127 ₹ crore+62.8% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin0.2 %−9.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit1.9 ₹ crore−67.8% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity-21.57 %+21.3 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-38.66 %−5.8 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)79.12 %+22.0 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

5 of 6 judged targets kept · 8 open · verdicts reflect calls analysed to Q1 FY27.

Zota Health Care LImited management guidance track record on Inve: 14 targets tracked across analysed earnings calls (5 achieved, 1 missed, 8 open).

TargetOriginal wordingSaidLatest callVerdict
COCO Store Additions800 to 900 more COCO stores in FY26
Call transcript, Q4 FY25 · 30 May 2025		Q4 FY25Q1 FY27:Promise relates to FY26 and was achieved. No new updates.
Call transcript, Q1 FY27 · 14 Aug 2026		Achieved
Marketing Spend % of SalesMarketing spend as a percentage of sales to remain broadly in a similar range going forward.
Call transcript, Q4 FY26 · 25 May 2026		Q4 FY26Q1 FY27:Marketing spend was INR 15-17 cr in Q1 alone (vs INR 18 cr for all of FY26), causing other expenses as a % of sales to jump significantly from 21% to 33%. This contradicts the guidance of maintaining the ratio.
Call transcript, Q1 FY27 · 14 Aug 2026		Missed
Gross MarginsExpect our gross margins to improve steadily
Call transcript, Q4 FY25 · 30 May 2025		Q4 FY25Q1 FY27:Gross margin compressed QoQ to 61.96% due to rising input costs. Management states this is a temporary issue and expects margins to revert and improve in 1-2 quarters.
Call transcript, Q1 FY27 · 14 Aug 2026		At Risk

Source: Inve Guidance Tracker for Zota Health Care LImited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

1 of Zota Health Care LImited's 14 targets was missed. See which ones, and which are quietly gone. The 3 above are the free sample; 11 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹1,280 +7.10% · +₹84.8

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −15.9% 1Y

₹1.0k₹1.2k₹1.4k₹1.6kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 28 Oct 2025Q3 FY26 — 5 Feb 2026Q4 FY26 — 25 May 2026Q1 FY27 — 14 Aug 2026

1Y: ₹1,521.5 on 24 Oct 2025 → ₹1,280. High ₹1,687 (15 Dec 2025), low ₹1,028.1 (1 Sept 2026).

Previous close
₹1,195.2
Market cap
₹4.1k Cr
52-week range
₹1,028.1 – ₹1,687
One year
−18.52%
Return on equity (TTM to Jun 2026)
-21.57%

Overview

Symbol
NSE:ZOTA
Exchange
NSE
Currency
INR

What Zota Health Care LImited does

Based on the company's own presentations, annual report and earnings calls.

Zota Health Care is an integrated pharmaceutical company built around Davaindia, a retail generic-pharmacy chain it runs through company-owned (COCO) and franchisee-owned (FOFO) stores selling private-label medicinal, OTC and ayurvedic products at a discount to branded equivalents. Its domestic marketing business procures finished-dose formulations from third-party WHO-GMP manufacturing partners and sells them under its own brand portfolio through a nationwide network of distributors who supply retail pharmacies. A separate exports division manufactures formulations at its own WHO-GMP certified plant at Sachin SEZ, Surat, and sells them under company-held marketing authorisations in overseas markets. The company also holds a majority stake in Everyday Herbal Group, extending its portfolio into ayurvedic and OTC personal-care products as a backward-integration move.

Segments

  • Davaindia
  • Domestic
  • Exports
  • Everyday Herbal Group
Davaindia retail pharmacy stores
2,331 (1,438 company-owned COCO + 893 franchise FOFO)
Geographic reach of Davaindia network
23 states and 5 union territories
SKUs in Davaindia portfolio
2,000+
Own export manufacturing facility
WHO-GMP certified plant at Sachin SEZ, Surat, producing about 250 formulations
Export markets served
30+ countries
Regulatory dossiers in export markets
325 product approvals received out of 586 dossier applications filed
Founded 2000Headquarters Surat, GujaratEmployees 3,500 (FY2024-25) Company website

How the price took the results

close before → close after

Q1 FY27
−8.9%
14 Aug
Q4 FY26
−5.9%
25 May
Q3 FY26
−2.6%
5 Feb
Q2 FY26
−0.2%
28 Oct

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Zota Health Care LImited

Free account: one company. Everything above stays public.

Write why you follow Zota Health Care LImited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Healthcare companies

All Healthcare companies → · Healthcare earnings growth →

Learn to analyse Zota Health Care LImited

Guides on how to read this kind of business and the numbers that matter.